Citations

Clear

6273 citation(s) found for "To, Andrew".

Sex, education and race/ethnicity have distinct effects on amyloid and tau‐PET status
Groot, Colin , Rowe, Christopher C., Giessen, Elsmarieke van de, Flier, Wiesje M. van der, Pijnenburg, Yolande A.L., Visser, Pieter Jelle, Braber, Anouk den, Pontecorvo, Michael J. , Burnham, Samantha C., Lu, Ming , Jagust, William J., Baker, Suzanne L. , Harrison, Theresa, Gispert, Juan Domingo, Shekari, Mahnaz , Minguillón, Carolina, Smith, Ruben, Mattsson‐Carlgren, Niklas, Palmqvist, Sebastian, Strandberg, Olof, Stomrud, Erik, Brickman, Adam, Manly, Jennifer J., Lao, Patrick J., Kreisl, William Charles, Malpetti, Maura, O'Brien, John T, Jäger, Elena, Bischof, Gérard, Drzezga, Alexander, Xie, Fang, Mao, Xiaoxie, Guan, Yihui, Frisoni, Giovanni B, Peretti, Débora Elisa , Skoog, I., Kern, Silke, Sperling, Reisa A., Johnson, Keith A., Risacher, Shannon, Saykin, Andrew J., Carrillo, Maria C., Dickerson, Brad C., Apostolova, Liana G., Rabinovici, Gil D., Barthel, H, Messerschmidt, Konstantin, Vandenberghe, Rik, Laere, Koen J. Van, Spruyt, Laure , Petersen, Ronald, Jack, Clifford R., Franzmeier, Nicolai, Brendel, Matthias, Gnörich, Johannes, Benzinger, Tammie L.S., Lagarde, Julien, Sarazin, Marie , Villeneuve, Sylvia , Poirier, Judes, Seo, Sang Won, Gu, Yuna , Kim, Jun Pyo, Mormino, Beth C., Vossler, Hillary , Rosa‐Neto, Pedro, Therriault, Joseph, Rahmouni, Nesrine, Cash, David M, Schott, Jonathan M, Hanseeuw, Bernard J, Jansen, Willemijn J. , Joie, Renaud La, Rosen, Howard J., Johnson, Sterling C., Christian, Bradley T, Betthauser, Tobey J., Landau, Susan M., O'Bryant, Sid E., Hansson, Oskar H., Ossenkoppele, Rik, Prevent‐AD, ADNI, ADNI‐DOD, A‐Study, MCSA,, O’Brien, John T. , O'Brien, John Tiernan , Groot, Colin , Coomans, Emma M. , Rowe, Christopher C., Doré, Vincent , Feizpour, Azadeh , Giessen, Elsmarieke van de , Flier, Wiesje M. van der , Pijnenburg, Yolande A.L. , Visser, Pieter Jelle , Braber, Anouk den , Burnham, Samantha C. , Kennedy, Ian Andrew , Jagust, William J. , Harrison, Theresa M. , Gispert, Juan Domingo , Shekari, Mahnaz , Minguillón, Carolina , Smith, Ruben, Mattsson, Niklas , Palmqvist, Sebastian , Strandberg, Olof, Stomrud, Erik , Brickman, Adam M. , Luchsinger, Jose Alejandro , Manly, Jennifer J. , Lao, Patrick , Malpetti, Maura , Rowe, James B. , Bischof, Gérard N. , Drzezga, Alexander E. , Xie, Fang , Guan, Yihui , Garibotto, Valentina , Frisoni, Giovanni B. , Schöll, Michael , Kern, Silke , Sperling, Reisa Anne , Johnson, Keith A. , Risacher, Shannon L. , Saykin, Andrew J. , Carrillo, María C. , Dickerson, Bradford Clark , Apostolova, Liana G. , Rabinovici, Gil D. , Rullmann, Michael , Messerschmidt, Konstantin, Vandenberghe, Rik , Petersen, Ronald, Jack, Clifford R. , Franzmeier, Nicolai , Brendel, Matthias , Gnörich, Johannes , Benzinger, Tammie L.S. , Lagarde, Julien , Bottlaender, Michel , Poirier, Judes , Seo, Sang Won , Kim, Jun Pyo, Young, Christina B. , Rosa-Neto, Pedro , Therriault, Joseph , Rahmouni, Nesrine , Coath, William , Cash, David M. , Schott, Jonathan M. , Hanseeuw, Bernard , Salman, Yasmine , Malotaux, Vincent , Joie, Renaud La , Rosen, Howard J. , Johnson, Sterling C. , Christian, Bradley T. , Betthauser, Tobey J. , Landau, Susan , O’Bryant, Sid E. , Hansson, Oskar , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 8, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_105387 Get It

Abstract Background Sex, education and race/ethnicity are all associated with risk of Alzheimer's disease dementia. Here, we assess the effects of self‐reported sex, educational attainment and race/ethnicity on amyloid‐positivity, and tau‐PET‐positivity in 12,048 (7,394 cognitively unimpaired [CU], 2,177 MCI, and 2,477 dementia) individuals from 42 cohorts worldwide. Method Logistic generalized estimating equations were used to estimate frequency of amyloid‐positivity (using cohort‐specific thresholds for amyloid‐PET [84%] or CSF) and tau‐PET‐positivity (cohort‐specific thresholds of 2SD above mean temporal uptake in amyloid‐negative controls). We assessed: i) sex and APOEε4 ( N = 10,098) associations, to complement earlier findings of a higher frequency of tau‐positivity in females, ii) effects of lower/higher education ( N = 10,970; cohort‐specific median‐split), and iii) effects of race/ethnicity (non‐Hispanic White [hereafter: White], N = 4880; Asian, N = 116; Black or African‐American [hereafter: Black], N = 353; Hispanic, N = 356, only from Northern‐American cohorts). Outcomes were frequency of amyloid‐positivity in CU individuals only, and tau‐PET‐positivity in both amyloid‐positive (AB+) CU and cognitively impaired (CI, i.e. MCI and dementia) individuals. Interaction effects on the relationship between age and amyloid/tau‐positivity were assessed and only retained in the models when significant. Result Female sex was associated with an APOEε4 ‐independent increased frequency of amyloid‐positivity (β=0.51[0.22], p = 0.02) in CU and increase of tau‐positivity in both AB+CU (β=0.27[0.08]) and AB+CI (β=0.37[0.08], both p <0.01). Remarkably, tau‐positivity frequencies of female APOEε4 non‐carriers were equivalent to male APOEε4 carriers in AB+CI (Figure 1). No significant sex* APOE interactions were observed. In CU, higher education was associated with lower amyloid‐positivity frequency (β=‐0.12[0.05], p = 0.02). In contrast, among AB+CU, there was an age*education interaction effect that indicated more pronounced age effects on tau‐positivity in individuals with higher education (age*education:β interaction =0.03[0.01], p <0.01). There were no education effects in AB+CI (Figure 2). In CU, an age*race/ethnicity interaction effect was observed across all non‐White groups compared to White (Hispanic:β interaction =‐0.05[0.01], p <0.01; Black:‐0.04[0.01], p <0.01; Asian:‐0.02[0.01], p = 0.04). This suggests that the impact of age on amyloid‐positivity was less pronounced in non‐White groups. Furthermore, in AB+CI, Hispanic ethnicity was related to higher tau‐positivity frequency than White (β=0.51[0.22], p = 0.02; Figure 3). Conclusion In this multi‐center initiative comprised of clinical and community‐based cohorts, we observed that self‐reported sex, educational attainment and race/ethnicity were related to positivity‐frequencies of Alzheimer's disease pathology.
Characterizing amyloid and tau positron emission tomography‐based stages across the clinical continuum
Cody, Karly Alex , Sokołowski, Andrzej , Johns, Emily , Guerra, Lucah Medina, Dumitrescu, Logan, Durant, Alaina, Sathe, Aditi, Koran, Mary Ellen I. , Mez, Jesse, Saykin, Andrew J., Toga, Arthur W., Cuccaro, M. L., Tosun, Duygu, Insel, Philip S., Johnson, Sterling C., Harrison, Theresa, Hohman, Timothy J., Mormino, Elizabeth C., Cody, Karly A , Sokołowski, Andrzej, Winer, Joseph R. , Young, Christina B. , Younes, Kyan , Dumitrescu, Logan , Archer, Derek B. , Durant, Alaina, Mez, Jesse , Saykin, Andrew J. , Toga, Arthur W. , Cuccaro, Michael L. , Insel, Philip S. , Johnson, Sterling C. , Harrison, Theresa M. , Hohman, Timothy J. , Mormino, Elizabeth C.

Mayo Clinic

Alzheimer's & Dementia | January 8, 2026 | Volume: 22 | Issue: 1 | Pages: No page available

10.1002/alz.71017 | PMID 41505234 Get It

Abstract INTRODUCTION We standardized positron emission tomography (PET) data across multiple cohorts and tracers to characterize the frequency of amyloid and tau PET severity along the clinical continuum. METHODS Clinical stage was defined using cohort‐specific criteria and included cognitively unimpaired (CU), mild cognitive impairment (MCI), and dementia. Amyloid severity was staged using Centiloids (CL). Tau severity was staged using a hierarchical Braak‐based schema. The cumulative probabilities of PET‐based stages were estimated using ordinal logistic regressions. RESULTS Among 10,396 individuals (mean [standard deviation] age: 71.9 [7.1] years), amyloid levels ≥ 25 CL increased with age among CU and MCI, while amyloid levels ≥ 100 CL were most common in dementia. In 3295 with tau PET, tau severity increased with amyloid and clinical stage and showed complex associations with age. Within each clinical stage, the full spectrum of amyloid and tau PET severity was observed. DISCUSSION PET‐based staging revealed heterogeneous amyloid and tau burden along the clinical continuum. Highlights PET‐based staging is feasible across multiple cohorts and PET tracers. There is heterogeneity in amyloid and tau severity across the clinical spectrum. The frequency of amyloid and tau PET severity increased with clinical severity. The likelihood of tau PET severity differed by age, amyloid, and clinical severity.
Authentic or Algorithm? Assessing the Use of Generative Artificial Intelligence in Urology Residency Personal Statements
Dalvi, Jay R., Zganjar, A, Witten, Anna E., Pak, Raymond W., Pathak, Ram , Broderick, Gregory A., Lyon, Timothy D., Lyon, Timothy D. , Pak, Raymond W. , Zganjar, Andrew J., Lyon, Timothy D , Pak, Ray , Zganjar, Andrew

Mayo Clinic

Urology Practice | January 8, 2026 | Volume: 13 | Issue: 3 | Pages: 217-220

10.1097/upj.0000000000000969 | PMID 41505198 Get It

External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
Leuzy, Antoine , Raket, Lars Lau, Villemagne, Victor L., Klein, Gregory , Tonietto, Matteo, Olafson, Emily, Baker, Suzanne L. , Saad, Ziad S., Bullich, Santiago , Lopresti, Brian J. , Sanabria, Sandra , Boada, Mercè, Charil, A., Collins, Emily C., Collins, Jessica, Higuchi, Makoto, Hostetler, Eric D., Hutchison, R. Matthew, Iaccarino, Leonardo, Insel, Philip S., Irizarry, Michael C., Jack, Clifford R., Jagust, William J., Johnson, Keith A., Johnson, Sterling C., Karten, Yashmin, Marquié, Marta, Mathotaarachchi, Sulantha , Mintun, Mark A., Huang, Qi, Mao, Xiaxie, Gnörich, Johannes , Pappas, Ioannis, Petersen, Ronald, Chiotis, Konstantinos, Rabinovici, Gil D., Rosa‐Neto, Pedro, Schwarz, Christopher G, Smith, Ruben, Stephens, Andrew W., Whittington, Alex , Carrillo, M., Pontecorvo, Michael J. , Haeberlein, Samantha Budd , Dunn, Billy , Stephenson, Diane , Tatton, Nadine , Brendel, Matthias, Xie, Fang, Hansson, Oskar H., Rial, Alexis Moscoso , Rakêt, Lars Lau , Villemagne, Victor L. , Tonietto, Mattéo , Olafson, Emily, Lutz, Olivia , Boada, Merce , Betthauser, Tobey J. , Collins, Emily C. , Collins, Jessica, Gunn, Roger N. , Higuchi, Makoto, Hutchison, R. Matthew , Iaccarino, Leonardo , Insel, Philip S. , Irizarry, Michael C. , Jack, Clifford R. , Jagust, William J. , Johnson, Keith A. , Johnson, Sterling C. , Marquié, Marta , Ossenkoppele, Rik , Pappas, Ioannis , Petersen, Ronald C. , Chiotis, Konstantinos , Rabinovici, Gil D. , Rosa-Neto, Pedro , Schwarz, Christopher G. , Smith, Ruben, Stephens, Andrew W., Carrillo, María C. , Kolb, Hartmuth C. , Brendel, Matthias , Xie, Fang , Rowe, Christopher Cleon , Hansson, Oskar , Doré, Vincent

Mayo Clinic

Alzheimer's & Dementia | January 8, 2026 | Volume: 21 | Issue: S2 | Pages: No page available

10.1002/alz70856_106362 Get It

Abstract Background The Joint Propagation Model (JPM)‐based CenTauR scale was recently introduced to harmonize tau‐PET quantification across different radiotracers. This study examined how CenTauR harmonization enhances the comparability of tau‐PET quantification across matched cohorts using different tracers. The evaluation focused on three key aspects: (1) comparing tau‐PET positivity rates as defined by CenTauR, (2) evaluating its diagnostic accuracy for symptomatic AD, and (3) analyzing longitudinal changes in tau‐PET rates over time. Method The JPM, developed by the CPAD‐led Tau PET Harmonization Working Group (Leuzy et al., Alzheimers Dement. 2024; Figure 1A), models relationships between anchor point subjects and head‐to‐head tau‐PET SUVR data onto the CenTauR scale, providing conversion equations for multiple tracers. JPM equations were applied to [ 18 F]flortaucipir SUVR (Meta‐temporal ROI) data from 561 cognitively impaired participants in the ADNI and OASIS‐3 studies. Using ROC analysis, we determined the CenTauR cut‐off for positivity (T+) that maximized the Youden index for discriminating between FDA‐approved positive/negative visual reads. Three separate cohorts, scanned using [ 18 F]flortaucipir (ADNI), [ 18 F]MK‐6240 (CPAS), and [ 18 F]RO‐948 (BioFINDER‐2), were matched 1:1 by age, MMSE, amyloid‐β, and clinical diagnosis. CenTauR‐based metrics were compared across these cohorts. Result A cut‐off of 18 CenTauRs was found to optimally classify [ 18 F]flortaucipir PET visual reads (Figure 1B). The matching procedure identified 1089 participants (363 per cohort). The frequency of T+ using the 18 CenTauRs cut‐off for the Meta‐Temporal ROI was highly comparable across tracers across groups, except for the Aβ‐positive cognitively unimpaired group, where variability was more pronounced due to a smaller sample size (Figure 2A). Similarly, tau‐PET discriminative accuracy for symptomatic AD vs controls remained similar across [ 18 F]flortaucipir and [ 18 F]MK‐6240 (Figure 2B). In a separate sample of 212 matched participants from ADNI ([ 18 F]flortaucipir) and AIBL ([ 18 F]MK‐6240) with baseline and 1‐year follow‐up tau‐PET scans, 1‐year change in CenTauRs was comparable (Figure 2C). An exploratory voxelwise transformation, utilizing the Meta‐Temporal conversion equation in a representative case scanned with both [ 18 F]flortaucipir and [ 18 F]MK‐6240, demonstrates the potential for voxelwise CenTauR harmonization (Figure 3). Conclusion These analyses suggest that CenTauR harmonization increases the comparability of tau‐PET data acquired with different tracers. Additional validation analyses with larger cohorts including other radiotracers ([ 18 F]PI‐2620) are underway.
Traumatic Lunate Fracture Patterns and Outcomes of Treatment
Tunaboylu, Mehmet Furkan , Emanuels, Andrew, Loron, Ali Gharibi , Sarcon, Aida K. , Moran, Steven L., Tunaboylu, Mehmet Furkan , Morsy, Mohamed , Moran, Steven L.

Mayo Clinic

Journal of Wrist Surgery | January 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2772-2209 Get It

Abstract The purpose of this study was to evaluate the incidence and outcomes of traumatic lunate fractures in a Level I trauma center over a 20-year period. Traumatic lunate fractures are rare, making it difficult to determine their frequency, outcomes, and patterns in clinical practice. A retrospective evaluation of 57 patients was conducted at a single institution from 2000 to 2022. Imaging studies, including radiographs, computed tomography, and magnetic resonance imaging, were reviewed to confirm traumatic etiology and fracture pattern. Fifty-seven lunate fractures met inclusion criteria: 11 were isolated and 46 had associated carpal fractures. Treatment included immobilization in 31 patients and surgery in 26. At a mean follow-up of 20.5 months (range, 2–186), average wrist flexion–extension range of motion was 90 degrees (range, 45–160), and grip strength averaged 26 kg (range, 6–48). Patient-reported outcomes were collected at a mean of 105 months (range, 12–226), with mean scores of 27 for the Disabilities of the Arm, Shoulder, and Hand, 19 for the Patient-Rated Wrist Evaluation, and 77 for the Mayo Wrist Score. Complications included 25 cases of posttraumatic arthritis, 2 cases each of avascular necrosis (AVN), nonunion, and complex regional pain syndrome, and 1 hardware infection. Posttraumatic arthritis was more frequently observed in patients with dorsal intercalated segment instability (DISI), age over 50 years, and displaced fractures. Lunate fractures occur in conjunction with greater arc injuries. Volar pole fractures were the most common fracture type observed. Predictors of long-term osteoarthritis included age over 50 years, DISI deformity, and displaced fractures at the time of diagnosis. Surgical fixation methods resulted in comparable outcomes. Two lunates progressed to AVN, both of which occurred following open operative fixation. Prognostic, Level IV
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study
McNamara, Dennis M. , Cooper, Leslie, Arbel, Yaron, Bocchi, Edimar, Hamer, A. J. , Herdy, Artur Haddad , Kerneis, Mathieu, Liu, Peter P., Parker, Andrea B., Pocock, Stuart , Smith, Eldon R., Tang, W H Wilson, Torre-Amione, Guillermo, Tschöpe, Carsten , Group, ARCHER Study, Bocch, Edimar, Moreira, Maria da Consolação Vieira , Dytz, Eduardo, Neuenschwander, Fernando Carvalho , Silva, Luís Beck da, Pezel, Theo, Abtan, Jeremie, Puymirat, Étienne , Moravsky, Gil, Piltz, Xavier Alejandro, Orlev, Amir , Bhat, Pavan , Thomas, Georgia , Lin, David, Palmer, Brittany, Kerneis, Mathieu , Pocock, Stuart J , McNamara, Dennis M , Tschöpe, Carsten , Friedrich, Matthias G. , Arbel, Yaron , Bhimaraj, Arvind , Hamer, Andrew, Tang, W.H. Wilson , Torre‐Amione, Guillermo , Caramori, Paulo , Moura, Lídia Zytynski , Macedo, Ariane Vieira Scarlatelli , Albuquerque, Denílson Campos de , Beck-da-Silva, Luís , Lattuca, Benoît , Bouleti, Claire , Pezel, Théo , Abtan, Jérémie , Delmas, Clément , Huang, Florent , Roubille, François , Bochaton, Thomas , Piltz, Xavier, Zlotoff, Daniel A , Hofmeyer, Mark R. , Hamer, Andrew

Mayo Clinic

ESC Heart Failure | January 6, 2026 | Volume: 13 | Issue: 1 | Pages: No page available

10.1093/eschf/xvaf034 | PMID 41711722 Get It

Abstract Introduction Cannabidiol has been shown to exert significant anti-inflammatory effects and has demonstrated efficacy in murine models of autoimmune myocarditis, pericarditis, and heart failure. The ARCHER Study assessed whether a pharmaceutically produced cannabidiol formulation showed beneficial effects on cardiac magnetic resonance (CMR) endpoints known to predict prognosis in this patient population. Methods In a multicentre international double-blind placebo-controlled phase 2 study, we randomly assigned 109 patients within 10 days of CMR confirmed diagnosis of acute myocarditis to 12 weeks of pharmaceutically produced oral cannabidiol (active) or placebo. Dose was titrated up to 10 mg/kg of body weight twice daily. Primary endpoints were the difference in extracellular volume (ECV) and global longitudinal strain (GLS) measured by CMR at week 12. Other CMR endpoints included left-ventricular ejection fraction (LVEF), LV mass, intracellular volume (ICV), LV end-diastolic and end-systolic volumes (LVEDV, LVESV), and left-atrial end-systolic volume (LAESV). Results All randomized patients (56 active/53 placebo) completed the study with no loss to follow-up. Study drug appeared safe and well tolerated. Baseline mean ECV 38.9 ± 10.9 ml, GLS −15.3 ± 3.6%, and LVEF 60.6 ± 9.9% were consistent with mild to moderate myocarditis and predominantly intact LV function. Week 12 mean ECV was 33.6 ml in the active group and 37.3 ml in the placebo group, a difference of −3.7 ml, confidence interval (CI): −7.4 to 0.1; P = .0538; GLS was −16.0% in the active group and −15.9% in the placebo group, difference of −0.1, CI: −1.2 to 1.1; P = .90. Left ventricular mass was significantly reduced in the active group at 121.1 g compared to placebo 130.3 g, a difference of −9.2, CI: −16.4 to −2.1; P = .0117. In terms of remodelling, LAESV was significantly reduced in the active group (−8.1 ml; P = .0376) while the reduction in LVEDV failed to reach significance (−7.4 ml; P = .098). Conclusion In mild-to-moderate acute myocarditis, treatment with pharmaceutically manufactured cannabidiol was not associated with a statistically significant change in myocardial ECV or GLS, although a trend towards reduction in ECV was observed. In addition, improvement in other potential markers of myocardial recovery, including a significant reduction in LV mass, was seen in the active treatment group. Further investigation of the therapeutic potential of this therapy in inflammatory cardiac conditions is warranted.
Can Large Language Models Be a Viable Tool for Consensus Working Groups? Experience of the Ventral Rectopexy Expert Consensus Group
Larson, Ellen L. , Vermunt, Jane , Thiels, Cornelius A., Christensen, P., Collinson, Rowan , Cornish, Julie , D’Hoore, André , Gurland, Brooke , Mellgren, Anders, Bordeianou, Liliana , Perry, William , Group, On behalf of the Ventral Rectopexy Consensus AI Group and the Ventral Rectopexy Working, Thiels, Cornelius A. , Christensen, Peter , Larson, Ellen L , Vermunt, Jane V , Thiels, Cornelius A , Christensen, Peter , Collinson, Rowan J , Cornish, Julie A , Gurland, Brooke H , Ratto, Carlo , Ris, Frederic , Bordeianou, Liliana G , Perry, William R , Lee, Frank G. , Ris, Frédéric , Stevenson, Andrew R. L.

Mayo Clinic

Diseases of the Colon & Rectum | January 6, 2026 | Volume: 69 | Issue: 5 | Pages: 836-846

10.1097/dcr.0000000000004058 | PMID 41492895 Get It

BACKGROUND: The Ventral Rectopexy International Expert Panel recently published a consensus update on ventral rectopexy. The ability of large language models to synthesize the literature on ventral rectopexy without an explicit knowledge base was studied before the publication of the consensus. OBJECTIVE: To compare the responses and citations of different large language models on ventral rectopexy using the expert panel consensus as the reference standard. DESIGN: ChatGPT-4o, Gemini 1.5 Pro, and OpenEvidence were compared on content appropriateness (1 = inappropriate to 5 = appropriate), readability (Flesch reading ease), response length, citation fabrication, and citation quality per Oxford Levels of Evidence. The most content-appropriate chatbot response selected by the expert panel was de-identified and presented alongside the consensus text to 15 colorectal surgeons who attempted to identify the chatbot-generated text. SETTINGS: Questions were submitted from September 18 to 19, 2024. Analysis was performed before the online publication of the consensus on January 30, 2025. MAIN OUTCOME MEASURES: The main outcome measures included content appropriateness, fabricated citation rate, citation quality, and the accuracy of identifying human versus chatbot text by colorectal surgeons. RESULTS: OpenEvidence ranked highest for content appropriateness (mean 3.5/5), above Gemini (3.0/5) and ChatGPT (2.8/5; p < 0.001). ChatGPT was most verbose with the highest readability scores ( p = 0.021). ChatGPT fabricated 53% of citations; Gemini fabricated 12%; OpenEvidence fabricated 0% ( p < 0.001). All OpenEvidence citations were peer reviewed, with 40 of 117 (34%) citing level I to III studies compared with 46 of 94 (49%) of the references cited in the consensus ( p = 0.043). Chatbot-generated responses were identified with 28 of 51 (55%) accuracy. LIMITATIONS: Reproducibility may be affected due to the nature of large language models and the availability of the consensus after publication. CONCLUSIONS: OpenEvidence outperformed Gemini 1.5 Pro and ChatGPT-4o in content appropriateness and peer-reviewed citation quantity and quality. Chatbot-generated text was indistinguishable from expert-authored consensus to subject matter experts. Large language models, as an early-stage research tool, may be viable for future consensus working groups, provided transparent disclosure and rigorous oversight. See Video Abstract . ¿PUEDEN LOS MODELOS LINGÜÍSTICOS DE GRAN TAMAÑO SER UNA HERRAMIENTA VIABLE PARA LOS GRUPOS DE TRABAJO DE CONSENSO? LA EXPERIENCIA DEL GRUPO DE CONSENSO DE EXPERTOS EN RECTOPEXIA VENTRAL ANTECEDENTES: El Panel Internacional de Expertos en Rectopexia Ventral publicó recientemente una actualización consensuada sobre la rectopexia ventral. Antes de la publicación del consenso, se estudió la capacidad de los grandes modelos lingüísticos para sintetizar la bibliografía sobre la rectopexia ventral sin una base de conocimientos explícita. Objetivo: Comparar las respuestas y citas de diferentes grandes modelos lingüísticos sobre la rectopexia ventral utilizando el consenso del panel de expertos como estándar de referencia. DISEÑO: Se compararon ChatGPT-4o, Gemini 1.5 Pro y OpenEvidence en cuanto a la idoneidad del contenido (1 = inadecuado a 5 = adecuado), la legibilidad (índice de legibilidad de Flesch), la longitud de la respuesta, la fabricación de citas y la calidad de las citas según los niveles de evidencia de Oxford. La respuesta del chatbot más adecuada en cuanto al contenido seleccionada por el panel de expertos se anonimizó y se presentó junto con el texto del consenso a 15 cirujanos colorrectales que intentaron identificar el texto generado por el chatbot. ENTORNO: Las preguntas se enviaron los días 18 y 19 de septiembre de 2024. El análisis se realizó antes de la publicación del consenso en línea el 30 de enero de 2025. PRINCIPALES MEDIDAS DE RESULTADOS: Adecuación del contenido, tasa de citas inventadas, calidad de las citas, precisión en la identificación del texto humano frente al del chatbot por parte de los cirujanos colorrectales. RESULTADOS: OpenEvidence obtuvo la puntuación más alta en cuanto a la adecuación del contenido (media de 3,5/5), por encima de Gemini (3,0/5) y ChatGPT (2,8/5) (p<0,001). ChatGPT fue el más prolijo, con las puntuaciones más altas en legibilidad (p = 0,021). ChatGPT inventó el 53% de las citas; Gemini inventó el 12 %; OpenEvidence inventó el 0 % (p < 0,001). Todas las citas de OpenEvidence fueron revisadas por pares, con 40/117 (34 %) que citaban estudios de nivel I-III frente a 46/94 (49 %) de las referencias citadas en el consenso (p = 0,043). Las respuestas generadas por el chatbot se identificaron con una precisión del 28/51 (55 %). LIMITACIONES: Reproducibilidad debido a la naturaleza de los modelos de lenguaje grandes y a la disponibilidad del consenso tras la publicación. CONCLUSIONES: OpenEvidence superó a Gemini 1.5 Pro y ChatGPT-4o en cuanto a la idoneidad del contenido y la cantidad y calidad de las citas revisadas por pares. El texto generado por el chatbot era indistinguible del consenso redactado por expertos para los expertos en la materia. Los modelos de lenguaje grandes como herramienta de investigación en fase inicial pueden ser viables para futuros grupos de trabajo de consenso, siempre que se garantice una divulgación transparente y una supervisión rigurosa. ( AI-generated translation )
Weight Loss Trends in Women’s Wrestling and Potential Implications of Menstrual Cycle: A Narrative Review
Jagim, Andrew R. , Fields, Jennifer B. , Jones, Margaret T. , Jagim, Andrew R , Fields, Jennifer B

Mayo Clinic

Nutrients | January 6, 2026 | Volume: 18 | Issue: 2 | Pages: 182

10.3390/nu18020182 | PMID 41599796 Get It

Background/Objectives: Women’s wrestling is one of the fastest growing sports within the United States at the high school and collegiate level. Weight-class sports, such as wrestling, present unique challenges for female athletes, particularly in managing acute weight fluctuations associated with the menstrual cycle. However, less is known regarding how sex-specific physiology may influence weight management strategies among female wrestlers. The purpose of this review was to highlight current weight loss trends among high school and collegiate female wrestlers and summarize the physiological mechanisms driving potential menstrual-related fluid retention and subsequent changes in body mass or composition. Methods: A literature review was conducted to include studies evaluating weight loss trends in female wrestlers competing in the United States. Additional literature focused on fluid, body mass, and body composition changes throughout the menstrual cycle was also included. Results: Recent evidence has provided observational data that can be used to develop descriptive summaries of current body composition profiles and weight loss trends among female wrestlers. These data can help to quantify the typical magnitude of weight loss changes observed in female wrestlers competing at the high school and collegiate level within the United States. Conclusions: These findings help provide insight into the magnitude of weight loss wrestlers undergo in an effort to compete in their minimal weight class, thus informing practitioners of potential health risks and helping guide optimal weight management efforts.
Differences in Estimated vs Measured GFR Associations with Cognitive Function in African American Older Adults
Sanjanwala, Harshin U., Zhu, Xiaoqian , Windham, B Gwen, Shrestha, Srishti , Griswold, Michael , Rule, Andrew, Mosley, Thomas, Sullivan, Kevin, Windham, B. Gwen , Rule, Andrew D.

Mayo Clinic

Innovation in Aging | January 3, 2026 | Volume: 9 | Issue: Supplement_2 | Pages: No page available

10.1093/geroni/igaf122.2902 Get It

Abstract Impaired kidney function is a risk factor for cognitive decline and dementia, but most studies use serum creatinine-based equations to estimate kidney function as estimated glomerular filtration rate (eGFR); these equations include age, also a strong driver of cognitive impairment, and produce eGFR estimates with substantial error compared to gold-standard objective measures of GFR (mGFR). The purpose of this study was to determine eGFR and mGFR associations with cognitive function in African American adults, a population disproportionately impacted by both chronic kidney disease and dementia. We conducted a cross-temporal analysis of 368 participants (Age: 66.4 ± 7.4y, 75% Female) in the Genetic Epidemiology Network of Arteriopathy study with eGFR (CKD-EPI 2021 Creatinine Race-Free Equation) and mGFR assessed. eGFR was assessed using the CKD-EPI 2021 Creatinine Race-Free Equation and mGFR (urinary clearance of non-radiolabeled iothalamate). Memory (Rey Auditory Verbal Learning Test; RAVLT) and executive function (Digit Symbol Substitution Test; DSST) were assessed. Linear regression models were used to relate eGFR, mGFR, and serum creatinine to cognitive function with and without adjustment for age and sex. In unadjusted models, eGFR was positively associated with DSST scores (β = 0.19, 95%CI:0.11, 0.27) and RAVLT scores (β = 0.10, 95%CI:0.04, 0.16). mGFR was marginally associated with DSST scores (β = 0.07, 95%CI:-0.00, 0.14), but not RAVLT scores (β = 0.03, 95%CI:-0.01, 0.07). Associations of serum creatinine with cognitive function were mostly null to marginal. Age and sex adjustment greatly attenuated all associations. The observed differential renal function associations with cognition suggest age may largely explain prior reported associations.
Age- and Sex-Adjusted Myocardial Flow Reserve Percentiles for Personalized Cardiovascular Risk Assessment
Joseph, Lee , Trinquart, Ludovic , Lopez, Diana M. , Brandao, Simone , Brown, Jenifer M. , Divakaran, Sanjay , Huck, Daniel , Weber, Brittany N, Goldstein, Leanne Barrett , Hainer, J., Carre, Sylvain , Lemley, M A R K, Orozco, Giselle Ramirez, Blankstein, R., Dorbala, Sharmila, Alexanderson, Erick, Carvajal-Juarez, Isabel, Mason, Steve, Wopperer, Samuel, Rosamond, Thomas, Buechel, Ronny R. , Al-Mallah, Mouaz H, Travin, Mark I. , Berman, Daniel, Dey, D A M I N I, Slomka, PJ, Carli, M. Di, Dey, Damini , Divakaran, Sanjay , Hainer, Jon , Carvajal-Juarez, Isabel , Joseph, Lee , Hainer, Jon , Blankstein, Ron , Dorbala, Sharmila , Alexanderson, Erick , Carvajal-Juarez, Isabel , Acampa, Wanda , Packard, Rene R S , Rosamond, Thomas L , Buechel, Ronny R , Einstein, Andrew Jeffrey , Al-Mallah, Mouaz H , Slipczuk, Leandro , Slomka, Piotr J , Dey, Damini , Lopez, Diana M., Soares Brandão, Simone Cristina , Brown, Jenifer Michelle , Lemley, Mark , Liang, Jiaming , Packard, René R. Sevag , Le, Viet T. , Mason, Steve, Knight, Stacey , Chareonthaitawee, Panithaya , Wopperer, Samuel, Al‐Mallah, Mouaz H. , Slipczuk, Leandro , Berman, Daniel S.

Mayo Clinic

No container title available | December 31, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2025.12.30.25343223 | PMID 41503477 Get It

ABSTRACT Introduction Positron emission tomography (PET) myocardial flow reserve (MFR) is a robust indicator of coronary vascular health and a strong predictor of cardiovascular risk. Clinical guidelines typically use fixed MFR thresholds (e.g., <2.0) to stratify risk, yet this approach overlooks individual variation, particularly by age and sex. We aimed to establish age- and sex-adjusted MFR percentiles and to evaluate their prognostic and predictive performance for cardiovascular risk assessment, in comparison with conventional fixed-threshold MFR approach. Methods Using data from the REFINE PET registry (24,820 patients from 12 sites), we measured PET MFR and derived age- and sex-adjusted MFR reference percentiles using quantile regression in patients without known coronary artery disease. All patients were categorized into percentile-based quartile groups. The primary outcome for prognostic and prediction analyses was major adverse cardiovascular events (MACE), defined as all-cause mortality, myocardial infarction, or heart-failure hospitalization. Time-to-event associations were evaluated using covariate-adjusted survival models, with cumulative incidence and hazard ratios (HR) estimated at 1 and 5 years in the derivation dataset, an independent but similar validation dataset A, and a high-risk validation dataset B. Predictive performance for MACE was assessed using discrimination, calibration, and reclassification metrics, comparing percentile-based models with models using a fixed MFR threshold (<2.0). Results Among participants (mean age 66.5 years; median follow-up 3.6 years), age- and sex-adjusted MFR quartile groups were strong independent predictors of MACE, with adjusted HR increasing stepwise across quartile groups at both early and later follow-up. At 1 year, HR (95% CI) comparing the lowest to the highest quartile group were 4.06 (3.41–4.82) in the derivation cohort, 3.31 (2.32–4.71) in validation cohort A, and 2.35 (2.05–2.70) in validation cohort B. At 5 years, the corresponding HR were 2.18 (1.86–2.56), 1.77 (1.31–2.40), and 1.59 (1.36–1.86). Percentile-based models demonstrated consistently higher discrimination, better calibration, and greater net reclassification for MACE at both time points compared with fixed-threshold MFR models. Although 67.2% of patients had preserved MFR (>2.0), cardiovascular risk increased steadily across MFR percentiles even within this range. Conclusion Age- and sex-adjusted MFR percentiles provide a reliable, clinically actionable measure of vascular health, improving cardiovascular risk stratification by better capturing age- and sex-related heterogeneity in vascular risk. Compared with traditional fixed-threshold approaches, MFR percentiles demonstrate improved predictive performance for cardiovascular risk assessment across diverse patient populations. CLINICAL PERSPECTIVE What is new? In a large, multinational real-world registry of more than 24,000 patients undergoing PET MPI, we derived age- and sex-adjusted myocardial flow reserve (MFR) percentiles, establishing a lifespan-based reference framework with age-specific reference values. Age- and sex-adjusted MFR percentiles showed a strong, graded association with 1- and 5-year cardiovascular risk and demonstrated improved prognostic and predictive performance compared with fixed MFR thresholds and models without MFR across independent derivation and validation datasets, including a higher-risk cohort. Lower adjusted MFR percentiles were consistently associated with higher risk of major adverse cardiovascular events, including all-cause mortality, myocardial infarction, and heart-failure hospitalization. What are the clinical implications? Age- and sex-adjusted MFR percentiles provide a personalized, dynamic measure of coronary vascular health that improves cardiovascular risk stratification by accounting for age- and sex-related heterogeneity. A percentile-based approach may help clinicians better identify patients at elevated cardiovascular risk who may warrant closer monitoring or intensified preventive strategies, while avoiding unnecessary intervention in lower-risk individuals. By integrating macrovascular and microvascular dysfunction, age- and sex-adjusted MFR percentiles offer a clinically interpretable marker of vascular aging that may inform future research on aging biomarkers, novel therapeutics and cardiovascular risk assessment across the spectrum of atherosclerotic and microvascular disease.